Disruptor Profile: Pear Therapeutics, Inc.
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
The report provides information and insights into Pear Therapeutics, Inc.'s, including –
– Overview of the company and its product offering
– Detailed insight into its business model, company type and headquarter
– Information on partnership and funding
– Biography of top management.
Scope
– Pear Therapeutics Inc. (Pear) is a pioneer in software-based prescription digital therapeutics (PDT) for the treatment of severe diseases and serious medical conditions.
Reasons to Buy
– Gain insights into Pears’s business operations.
– Gain insights into funding and partnerships
– Gain understanding about its technology focus.
Novartis
EDBI Pte Ltd
Blue Water Life Science Fund LP
Bridge Builders Collaborative
5AM Venture Management LLC
Novartis AG
TrustBridge Partners
Arboretum Ventures LLC
Temasek Holdings (Private) Ltd
JAZZ Venture Partners L.P.
Table of Contents
Frequently asked questions
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.